MAPT and Alzheimer disease: The neuroprotection of DNLAs extract DDB may be relevant to attenuated AD-like cognitive failures, decreased neural and synaptic damage, promoted APP and Aβ clearance, and alleviated tau pathologies in 3 × Tg-AD mice.